Related Experiment Video
Updated: Aug 19, 2025
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
A Review Pertaining to SARS-CoV-2 and Autoimmune Diseases: What Is the Connection?
1Faculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia.
Abstract:
Coronavirus disease 2019 (COVID-19) is an infectious viral disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). It is known that infection with SARS-CoV-2 can lead to various autoimmune and autoinflammatory diseases. There are few reports in the literature on the association between SARS-CoV-2 and autoimmune diseases, and the number of reports has been increasing since 2020. Autoimmune diseases and SARS-CoV-2 infections are intertwined in several ways. Both conditions lead to immune-mediated tissue damage, the immune response is accompanied by the increased secretion of inflammatory cytokines and both conditions can be treated using immunomodulatory drugs. Patients with certain autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, type 1 diabetes, cardiac sarcoidosis, idiopathic pulmonary fibrosis, autoimmune hepatitis, multiple sclerosis and others, are more susceptible to SARS-CoV-2 infection, either because of the active autoimmune disease or because of the medications used to treat it. Conversely, SARS-CoV-2 infection can also cause certain autoimmune diseases. In this paper, we describe the development of autoimmune diseases after COVID-19 and the recovery from COVID-19 in people with autoimmune diseases.
Insights
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, causing COVID-19, can trigger new autoimmune diseases and increase susceptibility in those with pre-existing autoimmune conditions. This paper details the development and recovery of autoimmune diseases post-COVID-19.
Area of Science:
- Immunology
- Infectious Diseases
- Rheumatology
Background:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, leading to Coronavirus Disease 2019 (COVID-19), is increasingly associated with autoimmune and autoinflammatory conditions.
- Both SARS-CoV-2 infection and autoimmune diseases involve immune-mediated tissue damage, elevated inflammatory cytokines, and can be managed with immunomodulatory drugs.
- Patients with autoimmune diseases like lupus, rheumatoid arthritis, and multiple sclerosis exhibit heightened susceptibility to SARS-CoV-2 infection due to their condition or treatments.
Purpose of the Study:
- To explore the intricate relationship between SARS-CoV-2 infection and autoimmune diseases.
- To document the onset of autoimmune diseases following COVID-19.
- To describe the recovery process from COVID-19 in individuals with autoimmune conditions.
Main Methods:
- Literature review of reported cases and studies on SARS-CoV-2 and autoimmune diseases.
- Analysis of the immunological mechanisms linking viral infection and autoimmunity.
- Case study descriptions of autoimmune disease development post-COVID-19 and recovery.
Main Results:
- Evidence indicates that SARS-CoV-2 infection can precipitate the development of various autoimmune diseases.
- Individuals with pre-existing autoimmune conditions are at higher risk for severe COVID-19 outcomes.
- The study highlights the bidirectional interaction between viral infections and autoimmune responses.
Conclusions:
- SARS-CoV-2 infection presents a significant risk factor for the development of new-onset autoimmune diseases.
- Understanding this link is crucial for managing patients with autoimmune conditions during and after the COVID-19 pandemic.
- Further research is warranted to elucidate the precise pathogenic mechanisms and optimize therapeutic strategies.
